#injectiveWhenever the topic of on-chain comes up, people often think of a series of issues such as order book deficiencies, cross-chain troubles, high latency/high Gas, and lack of real assets. But why can $INJ gain favor from multiple Wall Street institutions? How can we strategically position ourselves to share in the benefits?

Compared to many public chains that want to carry everything,$INJ choosing the narrative of 'fully decentralized finance' comes at the cost of short-term TVL/speculation being less than other public chains. However, in the long run, a stronger technological moat for $INJ will be higher and more solid.

The first hands-on experience #lnjective truly made me feel that the platform is created from user needs, establishing a genuinely free and fair financial system. With hardcore technology, it allows ordinary people to participate effortlessly and without barriers.

For an old finance hand like me, the advantage of #injective is that: 1️⃣ Order confirmation is sub-second, gas fees are less than 0.01, and trading can even be done with zero gas, so someone like me who often trades at high frequency no longer has to worry about fees eating into my profits; 2️⃣ High transaction throughput ensures my order entry and exit points; 3️⃣ Most importantly, in addition to supporting perpetual contracts and spot trading, it also supports TradFi assets (U.S. stocks, bonds, gold, etc.). It is also the first chain to tokenize real assets like U.S. Treasuries and stocks, which will lead the RWA transformation in traditional finance.

#injective is not just a DeFi chain, but also positions itself as a "pioneer of financial revolution," eliminating the barriers to entry in global financial markets and allowing everyone to participate in the financial market.

Why do I say $INJ is actually worth laying out early? Because the value of $INJ is directly tied to the revenue actually generated by the public chain ecosystem. #Injective🔥 The ecosystem already covers DeFi, DEX, RWA, lending, NFTs, AI integration, and cross-chain tools. At the same time, the listed company Pineapple Financial has launched a $100 million INJ treasury strategy, and its first $8.9 million purchase has been fully staked! This is the most direct example of traditional capital positioning itself in Injective. In addition, three Wall Street financial institutions, including 21 Shares, have also submitted INJ ETF applications. This shows that this U.S.-based project is being recognized by the traditional capital market.

I think #injective ($INJ) is worth holding for the long term because Injective has a clear positioning and practical technology, and it is willing to take the long-term route. Unlike pure DeFi projects that are limited to crypto assets, it also brings real-world assets on-chain, building a "borderless, inclusive financial system." In this industry full of noise and speculation, being able to build infrastructure well and achieve sustainable development is always very important in any era. Injective's choice of "full-stack decentralized finance" is indeed a difficult path, but if every developer only focuses on immediate profits, when will our next generation be able to use real on-chain finance? When will every user be able to share in the dividends brought by finance?@Injective

INJ
INJ
7.917
+4.35%